Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.

Healthcare policy changes may increase uncompensated care, stressing hospitals and the 340B program, crucial for subsidizing low-income patient care. The 340B rebate model, starting in 2026, could ...

Hospital groups raise issues with 340B rebate pilot program citing cash flow, administrative costs, and unclear rebate denials risks.

Too many hospitals take advantage of 340B, intended to make medications affordable for low-income patients. A New York ...

Ten medications accounted for nearly one-third of 340B program-covered outpatient drugs in 2024, according to a Dec. 11 report.  The Health Resources and Services Administration, an HHS agency, ...

The name “340B” comes from the section of the U.S. Public Health Service Act of 1992 that requires pharmaceutical ...

All North Dakotans surely know the adage, “If it ain’t broke, don’t fix it.” Well, some North Dakota state lawmakers are test-driving a new concept: “If it is broke, pretend it’s not.” And the ...

Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...

The 340B Drug Pricing Program was meant to help low-income patients, writes Rick Dowlearn, but it’s being used by hospitals ...

An AHA blog examines new data released by the Health Resources and Services Administration on the growth of the 340B Drug ...